Margaret A. McLoughlin, Ph.D.

Margaret A. McLoughlin, Ph.D.

DirectoratIRulya Therapeutics· In proxies 2023–2025

Margaret A. McLoughlin, Ph.D. sits on 5 public boards.

Boards1

  • IRulya TherapeuticsDirector · 9 yr on the boardIndependentCompensation, Nominating and Corporate Governance—Paid as an executive

Board seats come from each company's latest proxy statement.

Experience

  1. IRulya TherapeuticsPublic company · 3 yr
    • Director2023 – Present · 3 yrStock in role -72%
  2. 4D Molecular TherapeuticsPublic company
    • Director? – PresentNo stock prices for these years
  3. 4D Molecular Therapeutics, System1 BiosciencesPublic company
    • Director? – PresentNo stock prices for these years
  4. Adapsyn BiosciencesPublic company
    • Director? – PresentNo stock prices for these years
  5. System1 BiosciencesPublic company
    • Director? – PresentNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?